87 related articles for article (PubMed ID: 17244920)
21. Mediastinal staging of lung cancer. Is mediastinoscopy still essential?
Kristensen S; Aaby C; Nielsen SM
Dan Med Bull; 1995 Apr; 42(2):192-4. PubMed ID: 7664577
[TBL] [Abstract][Full Text] [Related]
22. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.
Murakami I; Hiyama K; Ishioka S; Yamakido M; Kasagi F; Yokosaki Y
Clin Cancer Res; 2000 Feb; 6(2):526-30. PubMed ID: 10690534
[TBL] [Abstract][Full Text] [Related]
23. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer.
Albertucci M; DeMeester TR; Golomb HM; MacMahon HK; Ryan JW; Iascone C
Surgery; 1987 Oct; 102(4):652-9. PubMed ID: 2821640
[TBL] [Abstract][Full Text] [Related]
24. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
[TBL] [Abstract][Full Text] [Related]
25. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy.
Lee JD; Ginsberg RJ
Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587
[TBL] [Abstract][Full Text] [Related]
26. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
27. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.
Yasufuku K; Pierre A; Darling G; de Perrot M; Waddell T; Johnston M; da Cunha Santos G; Geddie W; Boerner S; Le LW; Keshavjee S
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1393-400.e1. PubMed ID: 21963329
[TBL] [Abstract][Full Text] [Related]
28. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
29. Is routine mediastinoscopy indicated for patients with T1 non-small cell lung cancer?
Dincer SI; Demir A; Akin H; Gunluoglu MZ; Metin M; Melek H; Gurses A
Indian J Chest Dis Allied Sci; 2006; 48(4):249-52. PubMed ID: 16970289
[TBL] [Abstract][Full Text] [Related]
30. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
31. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
32. Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer.
Johnson EA; Klimstra DS; Herndon JE; Catalano E; Canellos GP; Graziano SL; Kern JA; Green MR
Cancer Invest; 2002; 20(5-6):686-92. PubMed ID: 12197224
[TBL] [Abstract][Full Text] [Related]
33. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of lymph node metastasis in the contralateral mediastinum or scalene through mediastinoscopy and para-mediastinal small incision in potentially operable non-small cell lung cancer].
Zhang SY; Wang X; Rong TH; Zheng L; Zeng CG; Xie ZM; Yu H; Zhu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):629-31. PubMed ID: 18210888
[TBL] [Abstract][Full Text] [Related]
35. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871.
Carbone DP; Mitsudomi T; Chiba I; Piantadosi S; Rusch V; Nowak JA; McIntire D; Slamon D; Gazdar A; Minna J
Chest; 1994 Dec; 106(6 Suppl):377S-381S. PubMed ID: 7988268
[TBL] [Abstract][Full Text] [Related]
36. The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging.
Kuzdzał J; Zieliński M; Papla B; Urbanik A; Wojciechowski W; Narski M; Szlubowski A; Hauer L
Eur J Cardiothorac Surg; 2007 Jan; 31(1):88-94. PubMed ID: 17116398
[TBL] [Abstract][Full Text] [Related]
37. The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients.
Gunluoglu MZ; Melek H; Medetoglu B; Demir A; Kara HV; Dincer SI
Eur J Cardiothorac Surg; 2011 Aug; 40(2):287-90. PubMed ID: 21185733
[TBL] [Abstract][Full Text] [Related]
38. Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non-small cell lung cancer.
Turna A; Demirkaya A; Ozkul S; Oz B; Gurses A; Kaynak K
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):774-80. PubMed ID: 23778084
[TBL] [Abstract][Full Text] [Related]
39. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.
Tomizawa Y; Kohno T; Fujita T; Kiyama M; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Nakajima T; Yokota J
Oncogene; 1999 Jan; 18(4):1007-14. PubMed ID: 10023676
[TBL] [Abstract][Full Text] [Related]
40. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
